TScan Therapeutics, Inc. (TCRX) ownership: Top institutional holder: DC Funds, LP ($630.00M). Insider activity: Net Seller (0 buys, 5 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| DC Funds, LP | 630000.00 | $630.00M | 2026-03-31 |
| Lynx1 Capital Management LP | 8019148.00 | $8.10M | 2026-03-31 |
| BVF INC/IL | 5564290.00 | $5.62M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 2784792.00 | $2.81M | 2026-03-31 |
| VANGUARD GROUP INC | 2475733.00 | $2.48M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2154256.00 | $2.18M | 2026-03-31 |
| BlackRock, Inc. | 1840952.00 | $1.86M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1460285.00 | $1.47M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-20 | |
| Sell | null | 2026-05-20 | |
| Sell | null | 2026-05-20 | |
| Sell | null | 2026-05-20 | |
| Sell | null | 2026-05-20 |
Back to TCRX overview · TCRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.